Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial EDITORIAL COMMENT

被引：0
|
作者：
DiVasta, Amy D.
Feldman, Henry A.
Gallagher, Jenny Sadler
Stokes, Natalie A.
Laufer, Marc R.
Hornstein, Mark D.
Gordon, Catherine M.
机构：
[1] Childrens Hosp Boston, Boston Ctr Endometriosis, Div Gynecol, Div Adolescent Med, Boston, MA USA
[2] Childrens Hosp Boston, Boston Ctr Endometriosis, Clin Res Program, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[5] Hasbro Childrens Hosp, Div Adolescent Med, Providence, RI USA
[6] Hasbro Childrens Hosp, Div Endocrinol, Providence, RI USA
来源：
OBSTETRICAL & GYNECOLOGICAL SURVEY | 2015年 / 70卷 / 11期
关键词：
D O I：
10.1097/OGX.0000000000000249
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [1] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis A Randomized Controlled Trial
    DiVasta, Amy D.
    Feldman, Henry A.
    Sadler Gallagher, Jenny
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    [J]. OBSTETRICS AND GYNECOLOGY, 2015, 126 (03): : 617 - 627
  • [2] THE EFFECT OF HORMONAL ADD-BACK THERAPY IN ADOLESCENTS TREATED WITH A GONADOTROPIN RELEASING HORMONE (GNRH) AGONIST FOR ENDOMETRIOSIS: A RANDOMIZED TRIAL
    DiVasta, Amy D.
    Feldman, Henry A.
    Gallagher, Jenny Sadler
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    [J]. JOURNAL OF ADOLESCENT HEALTH, 2015, 56 (02) : S24 - S24
  • [3] The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial
    Gallagher, Jenny Sadler
    Feldman, Henry A.
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    DiVasta, Amy D.
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2017, 30 (02) : 215 - 222
  • [4] Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial
    Franke, HR
    van de Weijer, PHM
    Pennings, TMM
    van der Mooren, MJ
    [J]. FERTILITY AND STERILITY, 2000, 74 (03) : 534 - 539
  • [5] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Kristof Chwalisz
    Eric Surrey
    Frank Z. Stanczyk
    [J]. Reproductive Sciences, 2012, 19 : 563 - 571
  • [6] Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy
    Bedaiwy, Mohamed A.
    Allaire, Catherine
    Alfaraj, Sukinah
    [J]. FERTILITY AND STERILITY, 2017, 107 (03) : 537 - 548
  • [7] The Hormonal Profile of Norethindrone Acetate: Rationale for Add-Back Therapy With Gonadotropin-Releasing Hormone Agonists in Women With Endometriosis
    Chwalisz, Kristof
    Surrey, Eric
    Stanczyk, Frank Z.
    [J]. REPRODUCTIVE SCIENCES, 2012, 19 (06) : 563 - 571
  • [8] Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?
    Surrey, Eric S.
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (04) : 283 - 288
  • [9] Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?
    Surrey, ES
    [J]. FERTILITY AND STERILITY, 1999, 71 (03) : 420 - 424
  • [10] Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and ''add-back'' therapy
    Murray, SC
    Muse, KN
    [J]. FERTILITY AND STERILITY, 1997, 67 (02) : 390 - 393
12345